Suchergebnisse - "Okada, Annabelle A"

PubPharm (12)

1

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2024

von Kataoka, K. | Itagaki, K. | Hashiya, N. | +41

2

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study : 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +44

3

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen : subgroup and post-hoc analyses from the ALTAIR study

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2021

von Ohji, M. | Okada, A. | Sasaki, K. | +4

ErratumIn: Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2395-2396. - PMID 35366082

4

Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration : A Prospective Study

enthalten in: Ophthalmology. Retina | 2020

von Maruko, I. | Ogasawara, M. | Yamamoto, A. | +8

5

Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration : outcomes of Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2020

von Koizumi, H. | Yamamoto, A. | Ogasawara, M. | +6

6

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration : 52- and 96-Week Findings from ALTAIR : A Randomized Controlled Trial

enthalten in: Advances in therapy | 2020

von Ohji, M. | Takahashi, K. | Okada, A. | +45

7

Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy

enthalten in: Japanese journal of ophthalmology | 2018

von Ogasawara, M. | Koizumi, H. | Yamamoto, A. | +6

8

One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration

enthalten in: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde | 2017

von Yamamoto, A. | Okada, A. | Nakayama, M. | +2

9

Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration : Twelve-Month Results

enthalten in: Ophthalmology | 2016

von Koizumi, H. | Kano, M. | Yamamoto, A. | +5

10

One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy

enthalten in: Ophthalmology | 2015

von Yamamoto, A. | Okada, A. | Kano, M. | +5

CommentIn: Ophthalmology. 2016 Feb;123(2):e13-4. - PMID 26802715